remicade การใช้
- Until this year, Remicade had a clear advantage in the market.
- Kippel noted that Medicare pays for Remicade since it requires intravenous infusion.
- The second and third best selling were Enbrel and Remicade, respectively.
- Enbrel is made by Immunex and Remicade by Centocor.
- Remicade was approved for plaque psoriasis in September 2006.
- ReoPro and Remicade should prosper under Johnson & Johnson's management.
- Remicade is given by intravenous infusion every two months, or sometimes more frequently.
- Remicade is already approved to treat Crohn's disease, an intestinal disorder.
- Enbrel is made byImmunex and Remicade by Centocor.
- They include the breast cancer drug Herceptin and Remicade, a rheumatoid arthritis medication.
- Remicade, and more patients benefited from treatments with other anti-TNF agents.
- Klippel said that Enbrel and Remicade have brought dramatic relief to many rheumatoid arthritis sufferers.
- Remicade is not part of the suit.
- According to the federal government, Medicare's payments for Remicade skyrocketed last year.
- Studies show Humira is safer than Remicade.
- Remicade and Enbrel, which were approved in 1998, are in a heated marketing battle.
- Physicians and analysts said Humira is as effective in treating rheumatoid arthritis as Enbrel and Remicade.
- Enbrel and Remicade will compete with Arava, the arthritis drug approved by the FDA in September.
- Johnson & Johnson's Remicade has garnered strength amid Enbrel's paltry production levels.
- Centocor Inc . used the meeting to show its experimental drug Remicade also provides relief from rheumatoid arthritis.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3